Intangible Asset Strategy Drives Growth
Grew company from $50M to $350M in 5 years
The Situation
- Generic manufacturer developed new combination drug
- Based on the initial advice the company received, the drug could not be effectively protected
The Client
Management Team: $50M+ Pharmaceutical Company
Outcome
- EverEdge was brought in to develop an intangible asset strategy that enabled the company to create significant barriers to entry
- The product was launched to great success and led to a dramatic increase in client growth
Result
Grew company from $50M to $350M in 5 years